Structure-function relationships among human cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities

Journal of Immunology

Volumn 174, Issue 7, 2005, Pages 4271-4278

  Braff, Marissa H ^a   Hawkins, Mi'i A ^a   Di Nardo, Anna ^a,c   Lopez Garcia, Belen ^a   Howell, Michael D ^b   Wong, Cathy ^a   Lin, Kenneth ^a   Streib, Joanne E ^b   Dorschner, Robert ^a   Leung, Donald Y M ^b   Gallo, Richard L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CATHELICIDIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; PERTUSSIS TOXIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA MICROARRAY; DRUG ANTAGONISM; DRUG BINDING; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; KERATINOCYTE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL CHEMOTAXIS; NEWBORN; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 20144367318     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.7.4271     Document Type: Article

References (54)

1. Kupper, T. S., and R. C. Fuhlbrigge. 2004. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 4:211.
2. Gallo, R. L., M. Ono, T. Povsic, C. Page, E. Eriksson, M. Klagsbrun, and M. Bernfield. 1994. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA 91:11035.
3. Frohm, M., B. Agerberth, G. Ahangari, M. Stahle-Backdahl, S. Liden, H. Wigzell, and G. H. Gudmundsson. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:15258.
4. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 1997. A peptide antibiotic from human skin. Nature 387:861.
5. Bardan, A., V. Nizet, and R. L. Gallo. 2004. Antimicrobial peptides and the skin. Expert Opin. Biol. Ther. 4:543.
6. Zanetti, M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukocyte Biol. 75:39.
7. Howell, M. D., J. F. Jones, K. O. Kisich, J. E. Streib, R. L. Gallo, and D. Y. Leung. 2004. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J. Immunol. 172:1763.
8. Larrick, J. W., M. Hirata, J. Zhong, and S. C. Wright. 1995. Anti-microbial activity of human CAP18 peptides. Immunotechnology 1:65.
9. Gudmundsson, G. H., B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238:325.
10. Bals, R., X. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95:9541.
11. Frohm Nilsson, M., B. Sandstedt, O. Sorensen, G. Weber, N. Borregaard, and M. Stahle-Backdahl. 1999. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67:2561.
12. Murakami, M., T. Ohtake, R. A. Dorschner, B. Schittek, C. Garbe, and R. L. Gallo. 2002. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol. 119:1090.
13. Dorschner, R. A., V. K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G. H. Gudmundsson, and R. L. Gallo. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A streptococcus. J. Invest. Dermatol. 117:91.
14. Sorensen, O. E., P. Follin, A. H. Johnsen, J. Calafat, G. S. Tjabringa, P. S. Hiemstra, and N. Borregaard. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with protein-ase 3. Blood 97:3951.
15. Niyonsaba, F., K. Iwabuchi, A. Someya, M. Hirata, H. Matsuda, H. Ogawa, and I. Nagaoka. 2002. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106:20.
16. Agerberth, B., J. Charo, J. Werr, B. Olsson, F. Idali, L. Lindbom, R. Kiessling, H. Jornvall, H. Wigzell, and G. H. Gudmundsson. 2000. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96:3086.
17. Davidson, D. J., A. J. Currie, G. S. Reid, D. M. Bowdish, K. L. MacDonald, R. C. Ma, R. E. Hancock, and D. P. Speert. 2004. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172:1146.
18. Heilborn, J. D., M. F. Nilsson, G. Kratz, G. Weber, O. Sorensen, N. Borregaard, and M. Stahle-Backdahl. 2003. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120:379.
19. Yang, D., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192:1069.
20. Elssner, A., M. Duncan, M. Gavrilin, and M. D. Wewers. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J. Immunol. 172:4987.
21. Tjabringa, G. S., J. Aarbiou, D. K. Ninaber, J. W. Drijfhout, O. E. Sorensen, N. Borregaard, K. F. Rabe, and P. S. Hiemstra. 2003. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171:6690.
22. Murakami, M., B. Lopez-Garcia, M. Braff, R. A. Dorschner, and R. L. Gallo. 2004. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172:3070.
23. Bowdish, D. M., D. J. Davidson, D. P. Speert, and R. E. Hancock. 2004. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172:3758.
24. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169:3883.
25. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454.
26. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151.
27. Mizutani, H., R. Black, and T. S. Kupper. 1991. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) β: different strategies of IL-1 production and processing in monocytes and keratinocytes. J. Clin. Invest. 87:1066.
28. Garcia-Ramallo, E., T. Marques, N. Prats, J. Beleta, S. L. Kunkel, and N. Godessart. 2002. Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J. Immunol. 169:6467.
29. Buckley, C. D., D. Pilling, J. M. Lord, A. N. Akbar, D. Scheel-Toellner, and M. Salmon. 2001. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22:199.
30. Van Wetering, S., S. P. Mannesse-Lazeroms, M. A. Van Sterkenburg, M. R. Daha, J. H. Dijkman, and P. S. Hiemstra. 1997. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am. J. Physiol. 272:L888
31. Chan, Y. R., M. Zanetti, R. Gennaro, and R. L. Gallo. 2001. Anti-microbial activity and cell binding are controlled by sequence determinants in the antimicrobial peptide PR-39. J. Invest. Dermatol. 116:230.
32. Shin, S. Y., K. W. Lee, Y. Kim, J. I. Kim, K. S. Hahm, and S. W. Kang. 2002. Structure-antibacterial activity relationship of cecropin A derivatives. Protein Pept. Lett. 9:487.
33. Shin, S. Y., M. K. Lee, K. L. Kim, and K. S. Hahm. 1997. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. J. Pept. Res. 50:279.
34. Hobta, A., I. Lisovskiy, S. Mikhalap, D. Kolybo, S. Romanyuk, M. Soldatkina, N. Markeyeva, L. Garmanchouk, S. P. Sidorenko, and P. V. Pogrebnoy. 2001. Epidermoid carcinoma-derived antimicrobial peptide (ECAP) inhibits phosphorylation by protein kinases in vitro. Cell Biochem. Funct. 19:291.
35. Cismowski, M. J., A. Takesono, M. L. Bernard, E. Duzic, and S. M. Lanier. 2001. Receptor-independent activators of heterotrimeric G-proteins. Life Sci. 68:2301.
36. Knebel, A., H. J. Rahmsdorf, A. Ullrich, and P. Herrlich. 1996. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15:5314.
37. Weiss, F. U., H. Daub, and A. Ullrich. 1997. Novel mechanisms of RTK signal generation. Curr. Opin. Genet. Dev. 7:80.
38. Daub, H., F. U. Weiss, C. Wallasch, and A. Ullrich. 1996. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557.
39. Daub, H., C. Wallasch, A. Lankenau, A. Herrlich, and A. Ullrich. 1997. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16:7032.
40. Gao, Y., S. Tang, S. Zhou, and J. A. Ware. 2001. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J. Pharmacol. Exp. Ther. 296:426.
41. Yan, Y., K. Shirakabe, and Z. Werb. 2002. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158:221.
42. Prenzel, N., E. Zwick, H. Daub, M. Leserer, R. Abraham, C. Wallasch, and A. Ullrich. 1999. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884.
43. Rosette, C., and M. Karin. 1996. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274:1194.
44. Rosen, L. B., and M. E. Greenberg. 1996. Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. Proc. Natl. Acad. Sci. USA 93:1113.
45. Liu, W., A. A. Akhand, M. Kato, I. Yokoyama, T. Miyata, K. Kurokawa, K. Uchida, and I. Nakashima. 1999. 4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J. Cell Sci. 112:2409.
46. Ruiter, G. A., M. Verheij, S. F. Zerp, W. H. Moolenaar, and W. J. Van Blitterswijk. 2002. Submicromolar doses of alkyl-lysophospholipids induce rapid internalization, but not activation, of epidermal growth factor receptor and concomitant MAPK/ERK activation in A431 cells. Int. J. Cancer 102:343.
47. Takeuchi, K., M. Kato, H. Suzuki, A. A. Akhand, J. Wu, K. Hossain, T. Miyata, Y. Matsumoto, Y. Nimura, and I. Nakashima. 2001. Acrolein induces activation of the epidermal growth factor receptor of human keratinocytes for cell death. J. Cell Biochem. 81:679.
48. Rubio, I., K. Rennert, U. Wittig, and R. Wetzker. 2003. Ras activation in response to lysophosphatidic acid requires a permissive input from the epidermal growth factor receptor. Biochem. J. 376:571.
49. Downward, J. 2003. Role of receptor tyrosine kinases in G-protein-coupled receptor regulation of Ras: transactivation or parallel pathways? Biochem. J. 376:e9
50. Gudmundsson, G. H., and B. Agerberth. 1999. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J. Immunol. Methods 232:45.
51. Risso, A. 2000. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J. Leukocyte Biol. 68:785.
52. Bals, R., and J. M. Wilson. 2003. Cathelicidins: a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 60:711.
53. Kamysz, W., and M. Okroj. 2003. Novel properties of antimicrobial peptides. Acid Biochim. Pol. 50:461.
54. Yang, D., and J. J. Oppenhein. 2004. Antimicrobial proteins act as "alarmins" in joint immune defense. Arthritis Rheum. 50:3401.